Improving Efficacy of Colorectal Cancer Treatments with Ulf Jungnelius MD Isofol Medical

Published: Feb. 11, 2020, 4:17 p.m.

Ulf Jungnelius MD, CEO, Isofol Medical discusses the increasing incidence of colorectal cancer as a global issue and the current challenges in treating this devastating disease.\xa0 Dr. Jungnelius also talks about the company's drug candidate, arfolitixorin, currently being studied in a global Phase 3 clinical trial with the aim to improve the efficacy of standard of care chemotherapy for advanced colorectal cancer.

#colorectalcancer #CRC #ColonCancer #MetastaticColorectalCancer #chemotherapy #FirstLineTreatment

Isofolmedical.com

Download the transcript here